Ninety-day morbidity of robot-assisted redo surgery for recurrent rectal prolapse, mesh erosion and pelvic pain: lessons learned from 9 years' experience in a tertiary referral centre.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
PMID:

Abstract

AIM: With increasing follow-up of patients treated with minimally invasive ventral mesh rectopexy (VMR) more redo surgery can be expected for recurrent rectal prolapse, mesh erosion and pelvic pain. The aim of this study is to evaluate the 90-day morbidity of robot-assisted redo interventions.

Authors

  • Emma M van der Schans
    Department of Surgery, Meander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands. em.vander.schans@meandermc.nl.
  • Paul M Verheijen
    Jan J van Iersel, Tim JC Paulides, Paul M Verheijen, Ivo AMJ Broeders, Esther CJ Consten, Meander Medical Centre, Department of Surgery, 3813 TZ Amersfoort, The Netherlands.
  • Ivo A M J Broeders
    Department of Robotics and Mechatronics, University of Twente, Enschede, the Netherlands.
  • Esther C J Consten
    Jan J van Iersel, Tim JC Paulides, Paul M Verheijen, Ivo AMJ Broeders, Esther CJ Consten, Meander Medical Centre, Department of Surgery, 3813 TZ Amersfoort, The Netherlands.